Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug BHV-1400 tested for kidney disease safety

NCT ID NCT07054684

First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 26 times

Summary

This early-stage study tests whether BHV-1400 is safe for people with IgA nephropathy, a kidney disease. About 20 adults with confirmed IgA nephropathy will receive the drug and be monitored for side effects. The goal is to check safety and tolerability, not yet to measure how well it works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IGA NEPHROPATHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Site-001

    RECRUITING

    Farmington, Connecticut, 06030, United States

  • Site-002

    RECRUITING

    Dakota Dunes, South Dakota, 57049, United States

  • Site-003

    RECRUITING

    Miami Lakes, Florida, 33016, United States

  • Site-004

    RECRUITING

    Houston, Texas, 77099, United States

  • Site-005

    RECRUITING

    Pembroke Pines, Florida, 33029, United States

  • Site-006

    RECRUITING

    Chesterfield, Missouri, 63017, United States

  • Site-007

    RECRUITING

    Leicester, LE5 4PW, United Kingdom

  • Site-008

    RECRUITING

    Lawrenceville, Georgia, 30046, United States

  • Site-009

    RECRUITING

    Hinsdale, Illinois, 60521, United States

  • Site-011

    RECRUITING

    Miami Lakes, Florida, 33172, United States

  • Site-012

    RECRUITING

    Indianapolis, Indiana, 46268, United States

  • Site-013

    RECRUITING

    Orlando, Florida, 32806, United States

Conditions

Explore the condition pages connected to this study.